Digital Health Acquisition CORP.: insider trades · United States · SEC (Form 4)

About Digital Health Acquisition CORP.

Digital Health Acquisition Corp. is a U.S.-listed company that was formed as a Delaware SPAC on March 30, 2021, with the purpose of completing a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination. Its principal executive offices were located at 980 N Federal Hwy #304 in Boca Raton, Florida, United States. The company raised about $115 million in its November 2021 IPO and positioned itself to pursue scalable healthcare and digital-health targets. For investors, that history matters because DHAC was designed as a transaction vehicle rather than a traditional operating business. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1864531/0001104659-23-095498-index.html)) From a business-model standpoint, DHAC did not build a broad standalone product franchise before its combination. Its core role was to identify and take public an attractive target in digital health, healthcare software, or technology-enabled services. That made its competitive position highly dependent on sponsor execution, deal sourcing, capital structure management, and the ability to complete a value-accretive transaction. In the crowded SPAC universe, that is a difficult niche: the company’s value proposition was essentially the quality of the merger it could deliver, not a legacy operating platform. ([nasdaq.com](https://www.nasdaq.com/press-release/digital-health-acquisition-corp.-announces-listing-transfer-to-the-nasdaq-capital)) The defining corporate event came on June 24, 2024, when Digital Health Acquisition Corp. closed its business combination with VSee Lab, Inc. and iDoc Virtual Telehealth Solutions, Inc. At closing, the company was renamed VSee Health, Inc., and it began trading on the Nasdaq under the ticker VSEE on June 25, 2024; the warrants trade under VSEEW. That transaction effectively transformed DHAC from a blank-check company into an operating digital-health platform. The combined business now links VSee Lab’s no-code/low-code telehealth SaaS workflow tools with iDoc’s high-acuity remote care capabilities for intensive care settings, including ICU and neuro-ICU coverage. ([s24.q4cdn.com](https://s24.q4cdn.com/622300748/files/doc_news/Digital-Health-Acquisition-Corp.-Announce-Closing-of-Business-Combination-Transaction-2024.pdf)) In strategic terms, the company now competes in the telehealth and digital-care infrastructure market, where larger software and healthcare technology players have deeper resources, broader customer relationships, and stronger distribution. VSee Health’s differentiation lies in workflow integration, rapid deployment, and its ability to combine software and clinical service layers into a single solution for hospitals and health systems. Recent public filings also indicate the company has been active in post-merger integration and financial reporting matters, including a later restatement-related disclosure, which underscores that execution risk remains material. For international investors, the key question is whether the merged platform can convert market demand for remote care into durable revenue growth and a credible long-term operating profile. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1864531/000155837025011813/vsee-20241231x10k.htm?utm_source=openai))